Pharmather

PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou…

Mar 2, 2021

PharmaTher Announces Research Collaboration with Terasaki Institute for Novel Microneedle Delivery of Psychedelic…

Feb 23, 2021

TDR’s Top 5 Psychedelic Developments For the Week of February 1

Feb 6, 2021

PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine

Feb 1, 2021

TDR’s Top 5 Psychedelic Developments For The Week of January 18

Jan 23, 2021

PharmaTher Signs Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and…

Jan 19, 2021

TDR’s Top 5 Psychedelic Developments For The Week of December 21

Dec 27, 2020

TDR’s Top 5 Psychedelic Developments For The Week of December 7

Dec 12, 2020

PharmaTher Files FDA Pre-IND Meeting Request for Ketamine in Parkinson’s Disease

Dec 8, 2020

TDR’s Top 5 Psychedelic Developments For The Week of November 30

Dec 5, 2020